Ambulatory Surgery Center EBITDA Valuation Multiples: 5x to 9x
Physician-owned ASCs with diversified payer mix, Medicare certification, and strong case volume command premium multiples from PE platforms and health systems.
Ambulatory Surgery Centers in the lower middle market ($1M–$5M revenue) typically trade at 5x to 9x EBITDA. Valuation is driven by payer mix quality, EBITDA margin, specialty diversification, accreditation status, and physician retention risk. PE roll-up buyers and regional health systems compete aggressively for certified, high-margin ASCs with clean compliance histories.
Ambulatory Surgery Center EBITDA Multiple Ranges by Tier
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed or Single-Specialty | $200K–$500K | 5x–6x | High physician concentration risk, aging equipment, weak payer mix, or unresolved CMS compliance issues suppress buyer interest and pricing. |
| Stable Independent ASC | $500K–$1M | 6x–7x | Medicare-certified, single-location ASC with solid margins but limited specialty mix or payer contract depth. Solid but not premium positioning. |
| Multi-Specialty Growth ASC | $1M–$2M | 7x–8x | Diversified specialty mix, strong payer contracts, AAAHC or Joint Commission accreditation, and documented case volume growth attract competitive bidding. |
| Premium Platform-Ready ASC | $2M+ | 8x–9x | PE roll-up ready with multiple OR suites, deep physician network, above-market reimbursement rates, and clean regulatory history command top-of-range multiples. |
What Drives Ambulatory Surgery Center Multiples
Payer Mix and Reimbursement Quality
High impactASCs with Medicare, commercial-dominant payer mix and locked-in above-average reimbursement rates for 2+ years achieve meaningfully higher multiples than Medicaid-heavy or uninsured-dependent centers.
Physician Ownership and Retention Risk
High impactRevenue concentrated among one or two surgeons creates key-man risk that compresses multiples. Buyers reward diversified physician partnerships with documented retention plans and rollover equity.
Accreditation and Regulatory Compliance
High impactAAAHC or Joint Commission accreditation and clean Medicare certification signal operational credibility. Unresolved CMS audits, overpayment demands, or CON violations are significant valuation discounts.
Specialty and Case Volume Mix
Medium impactOrthopedic, ophthalmology, and GI-heavy case mixes command buyer preference. Declining case volumes or heavy reliance on retiring physicians without succession plans reduce enterprise value materially.
EBITDA Margin and Operational Efficiency
Medium impactCenters sustaining 25%+ EBITDA margins through disciplined scheduling, supply chain management, and low overhead demonstrate scalability that PE buyers underwrite at premium acquisition multiples.
Recent Market Trends
PE-backed ASC roll-up activity intensified through 2023–2024 as CMS continued shifting high-acuity procedures to outpatient settings, expanding the addressable case mix. Competitive bidding from regional health systems has compressed cap rates on premium ASCs. Reimbursement rate uncertainty from CMS 2025 proposed rules is introducing modest valuation caution at the lower tier.
Sample Ambulatory Surgery Center Transactions
Two-OR orthopedic and pain management ASC in the Southeast, Medicare-certified, AAAHC accredited, diversified physician partnership with 6 active surgeons.
$1.4M
EBITDA
7.8x
Multiple
$10.9M
Price
Single-specialty GI-focused ASC in a Midwest suburban market, strong commercial payer contracts, stable case volume, sole physician-owner with partial rollover equity.
$650K
EBITDA
6.2x
Multiple
$4.0M
Price
Multi-specialty ASC with orthopedic, ophthalmology, and ENT service lines, three OR suites, Joint Commission accredited, acquired by PE-backed healthcare platform as add-on.
$2.1M
EBITDA
8.5x
Multiple
$17.9M
Price
EBITDA Valuation Estimator
Get your Ambulatory Surgery Center business value range instantly
Industry: Ambulatory Surgery Center · Multiples based on 6x–7x (Stable Independent ASC)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Frequently Asked Questions
What EBITDA multiple should I expect when selling my ambulatory surgery center?
Most ASCs sell at 5x to 9x EBITDA. Premium multiples require Medicare certification, diversified payer mix, multi-specialty case volume, strong margins, and clean compliance history.
Are ambulatory surgery centers eligible for SBA financing?
No. ASC acquisitions are not SBA-eligible due to healthcare regulatory complexity and physician ownership structures. Deals are typically structured through PE capital, health system balance sheets, or MSO frameworks.
How does physician concentration risk affect ASC valuation?
Heavy reliance on one or two surgeons for case volume creates key-man risk that buyers discount heavily. Diversified physician partnerships with retention agreements and rollover equity protect and enhance multiples.
How long does it take to sell a physician-owned ASC?
ASC transactions typically require 18 to 36 months from exit preparation to close due to licensing, accreditation transfer, payer contract assignment, and physician equity consensus requirements.
More Ambulatory Surgery Center Guides
Find Ambulatory Surgery Center businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required